Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory observational study of treatments to reduce scab stage in recurrent herpes labialis
2005-001384-60Phase 2Completed
- Sponsor
- GSK
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of acyclovir in herpes labialis, sponsored by GSK. Primary endpoints: Improvement in scab phase healing of recurrent herpes labialis and Safety (adverse events). Started Jun 2005; status: completed.
02
Drugs
acyclovir
03
Conditions
herpes labialis
Beyond the preview
Go deeper on 2005-001384-60.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001384-60.